Pro Pharma Communications International SRL
Pro Pharma Communications International reported total assets of 325,912 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Sep 2026).
By total assets for 2025, Pro Pharma Communications International ranks in the top half of the 149 companies in its sector (NACE 5813) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pro Pharma Communications International shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +122 % Total assets -9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pro Pharma Communications International's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 15,999 € | ||||
| Equity | 148,466 € | ||||
| Cash | 51,328 € | ||||
| EBITDA | 28,703 € | ||||
| Total assets | 325,912 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Sep 2026
- Year ended 31 Dec 2024filed on 24 Sep 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Pro Pharma Communications International's financial analysis
- Solvency45.6%sector median: 45.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pro Pharma Communications International
1 active director(s) in the register.
Pro Pharma Communications International's shareholders and holdings →Pro Pharma Communications International's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0812.290.965
- VAT number
- BE0812290965
- Peppol
- Registered · 0208:0812290965 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jun 2009
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 23 Sep 2026
- Activity
- Publishing of journals and periodicals (NACE 58130)
Pro Pharma Communications International (SRL) has been based in Mol since 2009, active in: publishing of journals and periodicals. For 2025, it reports a net profit of 15,999 € and equity of 148,466 €; its revenue is not published. Its solvency stands at 45.6%, above the median of its sector (45.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pro Pharma Communications International
Companies in the same business, of comparable size and area, outside its group.
- Uitgeverij - Edition Plaizier Publishing of journals and periodicals Brussels · balance sheet 493,170 €
- Courrier International EBL Publishing of journals and periodicals Etterbeek · balance sheet 342,148 €
- Media Access Publishing of journals and periodicals Bruges · balance sheet 310,268 €
- Members Only Publishing of journals and periodicals Lasne · balance sheet 231,440 €
- Wase Ontwikkelingsmaatschappij K.M.O. Projecten Publishing of journals and periodicals Sint-Niklaas · balance sheet 191,955 €
- Editions Maglife Publishing of journals and periodicals Lasne · balance sheet 190,005 €
- Imagemachine Publishing of journals and periodicals Forest · balance sheet 606,294 €
- Alnimmo Publishing of journals and periodicals Antwerp · balance sheet 174,137 €
Frequently asked questions about Pro Pharma Communications International
What is the revenue of Pro Pharma Communications International?
Pro Pharma Communications International files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pro Pharma Communications International?
In Belgium, the VAT number is the company number prefixed with BE: BE0812290965 for Pro Pharma Communications International, if the company is VAT-registered. Its company number (CBE) is 0812.290.965.
Where is the registered office of Pro Pharma Communications International?
According to the CBE register, the registered office of Pro Pharma Communications International is in 2400 Mol.
What is the equity of Pro Pharma Communications International?
At the close of the 2025 financial year, the equity of Pro Pharma Communications International amounts to 148,466 €, a solvency of 45.6% of total assets.
Who manages Pro Pharma Communications International?
The register lists 1 active mandates at Pro Pharma Communications International. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pro Pharma Communications International within its sector?
By total assets for 2025, Pro Pharma Communications International ranks in the top half of the 149 companies in its sector (NACE 5813) in Belgium that filed accounts for that financial year.
The full file of Pro Pharma Communications International
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →